Cassava Sciences Stock Forum

$Cassava Sciences(SAVA.US)$ New Promising Article: Cassava Sciences FLNA A will provide many benefits to Alzheimer's and possibly other diseases.

$Cassava Sciences(SAVA.US)$ New Bullish 4 K Filed Acquired more shares by SAVA Insider from Warrants

$Cassava Sciences(SAVA.US)$ Recent Bullish Buy SAVA Stock Rating!!!

$Cassava Sciences(SAVA.US)$ New Article on more benefits of  FLNA .  SAVA is definitely on the forefront of helping treat many diseases !

$Cassava Sciences(SAVA.US)$ We all knew this was going to save lives and improve cognition and more families will benefit from SAVA treating Alzheimer’s soon. Very Good News!!!

$Cassava Sciences(SAVA.US)$ As also shown in this article, People are losing their grandmothers, grandfathers,  mothers and fathers  to this  disease. A treatment is absolutely needed and SAVA is showing promise . How dare you, shorts? How dare you try to stop phase 3 trials, call it a sugar pill/ no better than placebo and blast accusation statements on twitter to delay the trials and attempt to destroy the company’s reputation so you can short it and make money knowing that you or your family ...

$Cassava Sciences(SAVA.US)$ Our Own Citizen's Petition should be to SEC & DOJ for short, false allegations and conflicts of interest from Bredt, Jordan Thomas, Adrian H, Jessee Brod, Bik since they have caused harm to the public by reporting false information against SAVA. They have harmed the public by delaying trials that were meant to assess a drug doing studies on volunteering patients with Alzheimers and they benefited by shorting the stock price and scaring the public. SAVA has now been in...

$Cassava Sciences(SAVA.US)$ Cassava Sciences’ Alzheimer’s Treatment Shows Promise: A Strong Buy Recommendation
The Naked shorting shares is wrong . Safety has been declared so continuous shorting at this point is flat out wrong and cheating the stock market and needs to be held accountable!

$Cassava Sciences(SAVA.US)$ Safety!!! Every SAVA process is showing good for FDA.
Cassava Sciences Completes Interim Safety Review Of Oral Simufilam On-Going Phase 3 Trials